3Niederman MS, Mandell LA, Aniueto A, et al. Guideline for the management of adult with community-acquired pneumonia, diagnosis, assessment of severity, antimicrobial therapy and prevention. Am J Respir Crit Care Med, 2001, 163 : 1730 - 1754.
46. Perry CM, Janvis B. Linezolid:a review of its use in the management of serious gram-positive infection. Drug, 2001, 61:525 - 551.
5Pfaller MA, Jones RN. Antimicmbial susceptibility of inducible AmpC β-lactamase-producing enterobacteriaceae from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme, Europe 1997-2000. Int J Antimicrob Agents, 2002, 19:383-388.
6Mandell LA, Bartlett JG, Dowell SF, et al. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis. 2003, 37 : 1405 - 1433.
7Liaw S J, Teng LJ, Hsueh PR, et al. In vitro activites of antimicrobial combination against clinical isolates of stenotrophomonas maltophilia.J Formos Med Assoc, 2002, 101:495 - 501.
